Mantis
M
Fundamental comparison between Mantis and MEDXT
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Mantis
MEDXT
Detailed Comparison
| Metric | Mantis | MEDXT |
|---|---|---|
| Price | $0.47447 | $0.000815 |
| Market Cap | $47.45M | $16.93M |
| 24h Volume | 4.7K | 216.6 |
| Rank | #0 | #944 |
| Circulating Supply | 100M | 20.8B |
| ATH | $4.84 | $0.003421 |
Mantis vs MEDXT — Analysis
Mantis and MEDXT are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 13 fundamental market, supply, capital and developer metrics.
Value Score Comparison
With a Value Score of 71.9, Mantis is currently rated as "undervalued", while MEDXT scores 59.6 and is rated "fair value". This means our algorithm considers Mantis the fundamentally stronger investment.
Market Cap & Risk
Mantis has a 3x larger market capitalization than MEDXT. A larger market cap typically means less volatility but also less growth potential. MEDXT may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, Mantis moved 0%, while MEDXT changed 0.41%. Looking at the 7-day window, Mantis is at -62.30% and MEDXT at -37.58%.
Distance from All-Time High
Mantis currently trades at 10% of its all-time high ($4.84), while MEDXT sits at 24% of its ATH ($0.003421). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, Mantis (Score: 71.9) currently has a stronger investment case than MEDXT (Score: 59.6). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.